26.02.2013 - The U.S. Food and Drug Administration said on Tuesday it has stopped all pediatric clinical trials of Amgen's Sensipar after the death of a 14-year-old patient taking part in a...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)